1. Home
  2. ALRS vs EOLS Comparison

ALRS vs EOLS Comparison

Compare ALRS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRS
  • EOLS
  • Stock Information
  • Founded
  • ALRS 1879
  • EOLS 2012
  • Country
  • ALRS United States
  • EOLS United States
  • Employees
  • ALRS N/A
  • EOLS N/A
  • Industry
  • ALRS Major Banks
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALRS Finance
  • EOLS Health Care
  • Exchange
  • ALRS Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • ALRS 548.4M
  • EOLS 493.5M
  • IPO Year
  • ALRS 2019
  • EOLS 2018
  • Fundamental
  • Price
  • ALRS $22.58
  • EOLS $7.66
  • Analyst Decision
  • ALRS Hold
  • EOLS Strong Buy
  • Analyst Count
  • ALRS 5
  • EOLS 5
  • Target Price
  • ALRS $25.30
  • EOLS $21.25
  • AVG Volume (30 Days)
  • ALRS 79.8K
  • EOLS 1.2M
  • Earning Date
  • ALRS 10-28-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • ALRS 3.72%
  • EOLS N/A
  • EPS Growth
  • ALRS 350.15
  • EOLS N/A
  • EPS
  • ALRS 1.59
  • EOLS N/A
  • Revenue
  • ALRS $252,130,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • ALRS $42.87
  • EOLS $14.01
  • Revenue Next Year
  • ALRS $2.77
  • EOLS $29.46
  • P/E Ratio
  • ALRS $14.18
  • EOLS N/A
  • Revenue Growth
  • ALRS 53.68
  • EOLS 17.15
  • 52 Week Low
  • ALRS $15.78
  • EOLS $5.71
  • 52 Week High
  • ALRS $24.41
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • ALRS 57.40
  • EOLS 50.21
  • Support Level
  • ALRS $22.03
  • EOLS $7.19
  • Resistance Level
  • ALRS $22.65
  • EOLS $7.67
  • Average True Range (ATR)
  • ALRS 0.49
  • EOLS 0.34
  • MACD
  • ALRS 0.09
  • EOLS 0.13
  • Stochastic Oscillator
  • ALRS 77.72
  • EOLS 79.29

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: